Literature DB >> 30396285

Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Kazushi Inoue1, Elizabeth A Fry1.   

Abstract

Recent studies have indicated that EGR1 is a direct regulator of tumor suppressors including TGFβ1, PTEN, and p53. The Myb-like transcription factor Dmp1 is a physiological regulator of the Arf-p53 pathway through transactivation of the Arf promoter and physical interaction of p53. The Dmp1 promoter has binding sites for Egr proteins, and Egr1 is a target for Dmp1. Crosstalks between p53 and PTEN have been reported. The Egr1-Dmp1-Arf-p53-Pten pathway displays multiple modes of interaction with each other, suggesting the existence of a functional network of tumor suppressors that maintain normal cell growth and prevent the emergence of incipient cancer cells.

Entities:  

Keywords:  ARF; DMP1 (DMTF1); EGR1; Nucleolus; Nucleus; PTEN; Signaling; Transcription; Tumor suppression; p53

Year:  2018        PMID: 30396285      PMCID: PMC6500763          DOI: 10.1080/07357907.2018.1533965

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  153 in total

1.  Akt phosphorylates myc-associated zinc finger protein (MAZ), releases P-MAZ from the p53 promoter, and activates p53 transcription.

Authors:  Wei-Ping Lee; Keng-Hsin Lan; Chung-Pin Li; Yee Chao; Han-Chieh Lin; Shou-Dong Lee
Journal:  Cancer Lett       Date:  2016-02-20       Impact factor: 8.679

2.  Repression of the c-myb gene by WT1 protein in T and B cell lines.

Authors:  S McCann; J Sullivan; J Guerra; M Arcinas; L M Boxer
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

3.  Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.

Authors:  Jun He; Jing-Jie Yu; Qing Xu; Lin Wang; Jenny Z Zheng; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 4.  Molecularly targeted therapies for p53-mutant cancers.

Authors:  Dekuang Zhao; William M Tahaney; Abhijit Mazumdar; Michelle I Savage; Powel H Brown
Journal:  Cell Mol Life Sci       Date:  2017-06-22       Impact factor: 9.261

5.  Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells.

Authors:  L Sauer; D Gitenay; C Vo; V T Baron
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

6.  Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.

Authors:  David Bertwistle; Masataka Sugimoto; Charles J Sherr
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

7.  DNA profiling by array comparative genomic hybridization (CGH) of peripheral blood mononuclear cells (PBMC) and tumor tissue cell in non-small cell lung cancer (NSCLC).

Authors:  Seung-Ho Baik; Bo-Keun Jee; Jin-Soo Choi; Hyoung-Kyu Yoon; Kweon-Haeng Lee; Yeul-Hong Kim; Young Lim
Journal:  Mol Biol Rep       Date:  2008-11-01       Impact factor: 2.316

Review 8.  MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer.

Authors:  Pankaj Taneja; Donna P Frazier; Robert D Kendig; Dejan Maglic; Takayuki Sugiyama; Fumitake Kai; Neetu K Taneja; Kazushi Inoue
Journal:  Expert Rev Mol Diagn       Date:  2009-07       Impact factor: 5.225

9.  Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.

Authors:  Ali Mallakin; Takayuki Sugiyama; Pankaj Taneja; Lauren A Matise; Donna P Frazier; Mayur Choudhary; Gregory A Hawkins; Ralph B D'Agostino; Mark C Willingham; Kazushi Inoue
Journal:  Cancer Cell       Date:  2007-10       Impact factor: 31.743

10.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.

Authors:  F Zindy; C M Eischen; D H Randle; T Kamijo; J L Cleveland; C J Sherr; M F Roussel
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

View more
  4 in total

1.  Targeting multiple genes containing long mononucleotide A-T repeats in lung cancer stem cells.

Authors:  Narumol Bhummaphan; Piyapat Pin-On; Preeyaporn Plaimee Phiboonchaiyanan; Jirattha Siriluksana; Chatchawit Aporntewan; Pithi Chanvorachote; Apiwat Mutirangura
Journal:  J Transl Med       Date:  2021-05-31       Impact factor: 5.531

2.  Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma.

Authors:  Cinzia Lanzi; Enrica Favini; Laura Dal Bo; Monica Tortoreto; Noemi Arrighetti; Nadia Zaffaroni; Giuliana Cassinelli
Journal:  J Exp Clin Cancer Res       Date:  2021-12-02

3.  From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis.

Authors:  Jihad Aljabban; Nilay Danis; Merve Gurakar; Kamal Khorfan; Nabeal Aljabban; Cem Simsek; Hussam Salhi; Maryam Panahiazar; Dexter Hadley; Ahmet Gurakar; Behnam Saberi
Journal:  Hepatol Forum       Date:  2020-01-17

4.  TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.

Authors:  Yuta Yamada; Naoki Kimura; Ken-Ichi Takayama; Yusuke Sato; Takashi Suzuki; Kotaro Azuma; Tetsuya Fujimura; Kazuhiro Ikeda; Haruki Kume; Satoshi Inoue
Journal:  Cancer Sci       Date:  2020-01-20       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.